Barclays: The RAPT Therapeutics (RAPT.US) rating was lowered from an increase in holdings to a wait-and-see rating, and the target price was adjusted from $13.00 to $4.00.
巴克莱：下调RAPT Therapeutics(RAPT.US)评级，由增持调整至持股观望评级, 目标价由13.00美元调整至4.00美元。
Barclays: The RAPT Therapeutics (RAPT.US) rating was lowered from an increase in holdings to a wait-and-see rating, and the target price was adjusted from $13.00 to $4.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.